Debt-to-equity of WEST PHARMACEUTICAL SERVICES INC from 30 Sep 2019 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
WEST PHARMACEUTICAL SERVICES INC quarterly Debt-to-equity in % history and change rate from 30 Sep 2019 to 31 Dec 2025.
  • WEST PHARMACEUTICAL SERVICES INC Debt-to-equity for the quarter ending 31 Dec 2025 was 35%, a 0.26% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

WEST PHARMACEUTICAL SERVICES INC Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2025 35% -0.09% -0.26% 31 Dec 2025
Q3 2025 35% +1% +2.9% 30 Sep 2025
Q2 2025 35% +1.4% +4.4% 30 Jun 2025
Q1 2025 35% +2% +6% 31 Mar 2025
Q4 2024 35% +1.9% +5.8% 31 Dec 2024
Q3 2024 34% +0.72% +2.2% 30 Sep 2024
Q2 2024 33% -0.83% -2.4% 30 Jun 2024
Q1 2024 33% -2.4% -6.9% 31 Mar 2024
Q4 2023 33% -4.3% -12% 31 Dec 2023
Q3 2023 33% -5.7% -15% 30 Sep 2023
Q2 2023 34% -7% -17% 30 Jun 2023
Q1 2023 35% -7.2% -17% 31 Mar 2023
Q4 2022 37% -7.2% -16% 31 Dec 2022
Q3 2022 39% -7.6% -16% 30 Sep 2022
Q2 2022 41% -7.4% -15% 30 Jun 2022
Q1 2022 43% -7.4% -15% 31 Mar 2022
Q4 2021 44% -5.8% -11% 31 Dec 2021
Q3 2021 47% -3.1% -6.2% 30 Sep 2021
Q2 2021 49% -0.05% -0.11% 30 Jun 2021
Q1 2021 50% +1.8% +3.6% 31 Mar 2021
Q4 2020 50% +2.5% +5.3% 31 Dec 2020
Q3 2020 50% +3.8% +8.3% 30 Sep 2020
Q2 2020 49% 30 Jun 2020
Q1 2020 48% 31 Mar 2020
Q4 2019 48% 31 Dec 2019
Q3 2019 46% 30 Sep 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.